首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1373398

全球耳管設備市場 - 2023-2030

Global Ear Tube Devices Market - 2023-2030

出版日期: 2023年10月18日 | 出版商:

DataM Intelligence | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

耳管裝置，也稱為鼓膜造口管或通氣管，是一種小型、通常為圓柱形的植入物，用於治療慢性滲出性中耳炎（中耳積液）或復發性耳部感染等疾病。這些管子透過小型外科手術插入耳膜，形成一個臨時通道，平衡壓力並從中耳排出液體。它們的主要目的是緩解症狀、改善聽力和預防復發感染。

耳管通常由不同的材料組成，例如矽膠、塑膠或金屬，根據其生物相容性和耐用性進行選擇。它們透過改善個人（尤其是兒童）的耳朵健康和整體生活品質，在治療持續性耳朵問題方面發揮著至關重要的作用。

市場動態：促進因素與限制因素

創新的耳管設計使用液體注入材料來增強耳部感染的治療效果，預計將推動市場成長

2023年，來自哈佛大學維斯仿生工程研究所、哈佛大學約翰·A·保爾森工程與應用科學學院以及波士頓馬薩諸塞州眼耳科的一組研究人員合作創造了一種革命性的新型耳管裝置，名為「鼓膜造口管」（TT）。這些管子採用液體注入材料，具有獨特的彎曲管腔形狀，可增強藥物輸送和液體引流並防止細菌黏附。

隨著創新 iTT「鼓膜造口管」(TT) 的推出，耳管設備市場預計將出現成長，這種創新 iTT 具有增強的功能和在人類患者中進行臨床試驗的潛力。這些 iTT 在解決傳統 TT 的局限性方面取得了重大進展，使其成為尋求改善耳部感染（尤其是兒童）治療方案的醫療保健提供者和家長的首選治療方案。該技術在其他植入式醫療導管（例如大腦和膽管分流器）的設計方法上具有多功能性，可擴大市場範圍並吸引更廣泛的醫療專業人員和患者。

因此，這項創新有可能為中耳疾病患者提供更安全、更有效率、可客製化的解決方案，從而徹底改變耳管設備市場。這將推動醫療保健產業的需求和投資。

此外，老年人口的不斷成長、人們對耳管益處的認知不斷提高、耳部感染髮生率的增加以及對微創手術的需求不斷增加，預計將在預測期內推動市場發展。

克制：

患者和醫療保健專業人員對耳管裝置的好處缺乏認知，有些患者或醫生可能更喜歡藥物治療或觀察等待等替代療法。此外，對與耳管插入相關的潛在併發症或副作用的擔憂可能進一步促成這種偏好。由於這些因素，耳管設備市場預計將在預測期內受到阻礙。

Ear tube devices, also known as tympanostomy tubes or ventilation tubes, are small, typically cylindrical implants used to treat conditions like chronic otitis media with effusion (fluid buildup in the middle ear) or recurrent ear infections. These tubes are inserted into the eardrum through a minor surgical procedure, creating a temporary passage that equalizes pressure and drains fluid from the middle ear. Their primary purpose is to alleviate symptoms, improve hearing, and prevent recurring infections.

Ear tubes are typically composed of different materials such as silicone, plastic, or metal, selected for their biocompatibility and durability. They play a vital role in treating persistent ear problems in individuals, especially children, by improving their ear health and overall quality of life.

Market Dynamics: Drivers and Restraints

Innovative ear tube design uses liquid-infused materials to enhance treatment results for ear infections is expected to drive market growth

In 2023, a team of researchers from the Wyss Institute for Biologically Inspired Engineering at Harvard University, Harvard John A. Paulson School of Engineering and Applied Sciences, and Massachusetts Eye and Ear in Boston collaborated to create a revolutionary new type of ear tube device called "tympanostomy tubes" (TTs). These tubes use a liquid-infused material and have a unique curved lumen shape that enhances drug delivery, and fluid drainage and prevents bacterial adhesion.

The ear tube devices market is expected to experience growth with the introduction of innovative iTTs "tympanostomy tubes" (TTs) that possess enhanced functionality and potential for clinical trials in human patients. These iTTs provide a significant advancement in addressing the limitations of conventional TTs, making them a preferred treatment option for healthcare providers and parents seeking improved treatment options for ear infections, especially in children. This technology's versatility in design approach for other implantable medical conduits, such as shunts for the brain and bile ducts, could expand the market's scope and appeal to a broader range of medical professionals and patients.

Therefore, this innovation has the potential to revolutionize the market for ear tube devices by providing safer, more efficient, and customizable solutions for patients with middle ear conditions. This will drive demand and investment in the healthcare sector.

Furthermore, the growing geriatric population, rising awareness about the benefits of ear tubes, increasing incidence of ear infections, and increasing demand for minimally invasive procedures are the factors expected to drive the market over the forecast period.

Restraint:

Lack of awareness among patients and healthcare professionals about the benefits of ear tube devices, and alternative treatments, such as medication or watchful waiting, may be preferred by some patients or physicians. Additionally, concerns about potential complications or side effects associated with ear tube insertion may further contribute to this preference. As a result of these factors, the market for ear tube devices is expected to hamper over the forecast period.

Segment Analysis

The global ear tube devices market is segmented based on material, indication, end user, and region.

The silicone tubes from the material segment accounted for approximately 36.6% of the ear tube devices market share

Silicone tubes are frequently used in ear tubes, also known as tympanostomy tubes or grommets. Their inherent softness, flexibility, and biocompatibility make them ideal for situations where patient comfort and compatibility with delicate bodily tissues are crucial. These qualities are highly valued in pediatric ear tube surgeries, where the gentle nature of silicone tubes helps to minimize the risk of tissue damage during insertion.

Additionally, they provide a comfortable and dependable solution for treating conditions like chronic ear infections and middle ear ventilation issues in young patients, ensuring their well-being throughout the treatment process. Furthermore, the increasing prevalence of ear disorders, growth in the number of children with ear issues, advantages of silicone tubes, and awareness about the benefits of ear tubes are the factors expected to drive the market over the forecast period.

For instance, the World Health Organization (WHO) has reported that there are currently 1.5 billion people around the world living with some level of hearing impairment. Out of this number, 430 million are facing disabling hearing loss. It is projected that by the year 2050, this number will rise to more than 700 million. Notably, over a quarter of individuals aged 60 and above grapple with disabling hearing loss, and approximately 30% of this age group suffer from some form of hearing impairment.

Also, globally, 34 million children are affected by deafness or hearing loss, with a concerning 60% of these cases stemming from preventable causes. This highlights the urgent need for hearing-related interventions, such as ear tube devices, to address hearing problems across different age groups and demographics. This is especially important for pediatric populations.

Moreover, Collar Button Ear Tubes represent a distinct category of silicone ear tubes known for their exceptional softness, flexibility, and elasticity. They are incredibly flexible and can be easily manipulated and compressed, which makes the process of insertion and removal simpler. This exceptional design feature makes Collar Button Ear Tubes a preferred choice for healthcare professionals who are looking to address ear-related conditions, as they provide a more user-friendly and efficient solution for patients requiring ear tube placement. Hence, owing to the above factors, the market segment is expected to hold the largest market share over the forecast period.

Geographical Analysis

North America accounted for approximately 40.7% of the market share in 2022

North America is expected to hold the largest market share owing to the FDA approvals of ear tube devices, the increasing prevalence of ear disorders, and the development of novel ear tube devices by research institutes.

For instance, on August 15, 2022, Preceptis Inc. was granted an expanded clearance by the U.S. FDA for its Hummingbird Tympanostomy Tube System, allowing for office-based pediatric ear tube procedures in all children six months and older. The device was previously cleared for children aged 6-24 months. The minimally invasive device is designed to create an incision in the ear canal, enabling the delivery of the ear tube in a single pass without requiring general anesthesia.

Additionally, in 2023, a new ear tube was developed by Harvard researchers to enhance treatment outcomes for patients with ear infections. The tube is made up of liquid-infused materials and optimized geometry to prevent blockages and improve performance. The design was created using a screening algorithm and has fluid transport properties. This innovative design is anticipated to decrease the number of visits for children suffering from chronic ear infections and improve results for patients with ear-related ailments. Thus, owing to the above factors, the North America region is expected to hold the largest market share over the forecast period.

COVID-19 Impact Analysis:

COVID-19 had a significant impact on the ear tube devices market. Otolaryngologists, along with their staff, are at a higher risk of contracting COVID-19 due to their direct exposure to mucus and aerosolized particles during procedures and examinations in the head and neck area. Reports from countries like China, Italy, Iran, and the United Kingdom indicate that otolaryngologists are among the most vulnerable to contracting the SARS-CoV-2 virus, especially if they are not wearing appropriate personal protective equipment (PPE).

Moreover, according to the National Center for Biotechnology Information, 2022, the incidence of otitis media was drastically reduced, the incidence of complications of otitis media was reduced, and the number of patients visiting the emergency room due to otitis media decreased.

Additionally, due to the COVID-19 pandemic, there has been a significant decrease in the rate of pediatric tympanostomy tube placement. The age of patients undergoing surgery has increased and more children are receiving care in a tertiary setting. These findings may indicate changes in the prevalence of acute and chronic otitis media caused by the pandemic.

Therefore, the COVID-19 pandemic impacted the use of ear tube devices by decreasing the number of tympanostomy tube placements, increasing the risk of infection, decreasing middle ear effusion, generating aerosols during myringotomy, and causing ear pressure.

Competitive Landscape

The major global players in the ear tube devices market include: Anthony Products, Inc., Olympus America, Adept Medical, Atos Medical AB, Summit Medical LLC, Medtronic, Smith+Nephew, Heinz Kurz GmbH Medizintechnik, Hummingbird TTS Preceptis Medical, and Invotec International Inc. among others.

Key Developments

On August 15, 2022, Preceptis Medical, Inc. is a surgical technology company that focuses on providing less invasive options for pediatric patients. The Hummingbird Tympanostomy Tube System (TTS) received clearance from the U.S. FDA for expanded indications for use in office-based pediatric ear tube procedures. This new labeling now allows in-office procedures for all children six months and older, whereas it was previously only cleared for children aged 6-24 months.
On June 2, 2021, Preceptis Medical launched its Hummingbird tympanostomy tube system for office-based pediatric ear tube procedures.
On January 24, 2020, Smith & Nephew acquired Tusker Medical for an undisclosed sum. Tusker Medical is the developer of the Tula System, an in-office ear tube delivery system used to treat recurrent or persistent ear infections. The pediatric ear tubes received FDA breakthrough device designation in November 2019.

Why Purchase the Report?

To visualize the global ear tube devices market segmentation based on material, indication, end user, and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of ear tube devices market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global ear tube devices market report would provide approximately 61 tables, 59 figures, and 186 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Material
3.2. Snippet by Indication
3.3. Snippet by End User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Innovative ear tube design using liquid-infused materials
- 4.1.2. Restraints
  - 4.1.2.1. Complications or side effects associated with ear tube insertion
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Pipeline Analysis
5.6. Patent Analysis
5.7. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Material

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 7.1.2. Market Attractiveness Index, By Material
7.2. Silicone Tubes*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Fluoroplastic Tubes
7.4. Metal Tubes
7.5. Others

8. By Indication

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 8.1.2. Market Attractiveness Index, By Indication
8.2. Otitis Media*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  - 8.2.2.1. Others
8.3. Eustachian Tube Dysfunction
8.4. Others

9. By End User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. ENT Clinics
9.4. Ambulatory Surgical Centers
9.5. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1. U.S.
  - 10.2.6.2. Canada
  - 10.2.6.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1. Germany
  - 10.3.6.2. UK
  - 10.3.6.3. France
  - 10.3.6.4. Spain
  - 10.3.6.5. Italy
  - 10.3.6.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1. Brazil
  - 10.4.6.2. Argentina
  - 10.4.6.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. China
  - 10.5.6.2. India
  - 10.5.6.3. Japan
  - 10.5.6.4. Australia
  - 10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Anthony Products, Inc.*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Olympus America
12.3. Adept Medical
12.4. Atos Medical AB
12.5. Summit Medical LLC
12.6. Medtronic
12.7. Smith+Nephew
12.8. Heinz Kurz GmbH Medizintechnik
12.9. Hummingbird TTS Preceptis Medical
12.10. Invotec International Inc.

LIST NOT EXHAUSTIVE